Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury

S. N. Batchu, S. B. Lee, R. S. Qadhi, K. R. Chaudhary, H. El-Sikhry, R. Kodela, J. R. Falck, J. M. Seubert

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background and Purpose Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase metabolites of arachidonic acid that are metabolized into dihydroxyepoxyeicosatrienoic acids (DHET) by soluble epoxide hydrolase (sEH). The current investigations were performed to examine the cardioprotective effects of UA-8 (13-(3-propylureido)tridec-8-enoic acid), a synthetic compound that possesses both EET-mimetic and sEH inhibitory properties, against ischaemia-reperfusion injury. Experimental Approach Hearts from C57BL/6 mice were perfused in Langendorff mode and subjected to ischaemia reperfusion. Mechanistic studies involved co-perfusing hearts with either 14,15-EEZE (a putative EET receptor antagonist), wortmannin or PI-103 (class-I PI3K inhibitor). H9c2 cells were utilized to investigate the protective effects against mitochondrial injury following anoxia reoxygenation. Key Results Perfusion of UA-8 significantly improved postischaemic left ventricular developed pressure (LVDP) and reduced infarction following ischaemia reperfusion compared with control and 11,12-EET. UA-7 (13-(2-(butylamino)-2-oxoacetamido) tridec-8(Z)-enoic acid), a compound lacking sEH inhibitory properties, also improved postischaemic LVDP, while co-perfusion with 14,15-EEZE, wortmannin or PI-103 attenuated the improved recovery. UA-8 prevented anoxia-reoxygenation induced loss of mitochondrial membrane potential and cell death in H9c2 cells, which was blocked by co-treatment of PI-103. Conclusions and Implications UA-8 provides significant cardioprotection against ischaemia reperfusion injury. The effects are attributed to EETs mimetic properties, which limits mitochondrial dysfunction via class-I PI3K signalling.

Original languageEnglish (US)
Pages (from-to)897-907
Number of pages11
JournalBritish Journal of Pharmacology
Volume162
Issue number4
DOIs
StatePublished - Feb 2011

Fingerprint

Epoxide Hydrolases
Reperfusion Injury
Ventricular Pressure
Phosphatidylinositol 3-Kinases
Reperfusion
Acids
Ischemia
Perfusion
Mitochondrial Membrane Potential
Inbred C57BL Mouse
Cytochrome P-450 Enzyme System
Infarction
Cell Death
Wounds and Injuries
PI103
wortmannin
Hypoxia
14,15-eicosa-5-enoic acid

Keywords

  • cardioprotection
  • EET surrogates
  • ischaemia-reperfusion
  • mitochondria and sEHi

ASJC Scopus subject areas

  • Pharmacology

Cite this

Batchu, S. N., Lee, S. B., Qadhi, R. S., Chaudhary, K. R., El-Sikhry, H., Kodela, R., ... Seubert, J. M. (2011). Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury. British Journal of Pharmacology, 162(4), 897-907. https://doi.org/10.1111/j.1476-5381.2010.01093.x

Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury. / Batchu, S. N.; Lee, S. B.; Qadhi, R. S.; Chaudhary, K. R.; El-Sikhry, H.; Kodela, R.; Falck, J. R.; Seubert, J. M.

In: British Journal of Pharmacology, Vol. 162, No. 4, 02.2011, p. 897-907.

Research output: Contribution to journalArticle

Batchu, S. N. ; Lee, S. B. ; Qadhi, R. S. ; Chaudhary, K. R. ; El-Sikhry, H. ; Kodela, R. ; Falck, J. R. ; Seubert, J. M. / Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury. In: British Journal of Pharmacology. 2011 ; Vol. 162, No. 4. pp. 897-907.
@article{5c38581403ae44a78e6c4e00d877512d,
title = "Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury",
abstract = "Background and Purpose Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase metabolites of arachidonic acid that are metabolized into dihydroxyepoxyeicosatrienoic acids (DHET) by soluble epoxide hydrolase (sEH). The current investigations were performed to examine the cardioprotective effects of UA-8 (13-(3-propylureido)tridec-8-enoic acid), a synthetic compound that possesses both EET-mimetic and sEH inhibitory properties, against ischaemia-reperfusion injury. Experimental Approach Hearts from C57BL/6 mice were perfused in Langendorff mode and subjected to ischaemia reperfusion. Mechanistic studies involved co-perfusing hearts with either 14,15-EEZE (a putative EET receptor antagonist), wortmannin or PI-103 (class-I PI3K inhibitor). H9c2 cells were utilized to investigate the protective effects against mitochondrial injury following anoxia reoxygenation. Key Results Perfusion of UA-8 significantly improved postischaemic left ventricular developed pressure (LVDP) and reduced infarction following ischaemia reperfusion compared with control and 11,12-EET. UA-7 (13-(2-(butylamino)-2-oxoacetamido) tridec-8(Z)-enoic acid), a compound lacking sEH inhibitory properties, also improved postischaemic LVDP, while co-perfusion with 14,15-EEZE, wortmannin or PI-103 attenuated the improved recovery. UA-8 prevented anoxia-reoxygenation induced loss of mitochondrial membrane potential and cell death in H9c2 cells, which was blocked by co-treatment of PI-103. Conclusions and Implications UA-8 provides significant cardioprotection against ischaemia reperfusion injury. The effects are attributed to EETs mimetic properties, which limits mitochondrial dysfunction via class-I PI3K signalling.",
keywords = "cardioprotection, EET surrogates, ischaemia-reperfusion, mitochondria and sEHi",
author = "Batchu, {S. N.} and Lee, {S. B.} and Qadhi, {R. S.} and Chaudhary, {K. R.} and H. El-Sikhry and R. Kodela and Falck, {J. R.} and Seubert, {J. M.}",
year = "2011",
month = "2",
doi = "10.1111/j.1476-5381.2010.01093.x",
language = "English (US)",
volume = "162",
pages = "897--907",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury

AU - Batchu, S. N.

AU - Lee, S. B.

AU - Qadhi, R. S.

AU - Chaudhary, K. R.

AU - El-Sikhry, H.

AU - Kodela, R.

AU - Falck, J. R.

AU - Seubert, J. M.

PY - 2011/2

Y1 - 2011/2

N2 - Background and Purpose Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase metabolites of arachidonic acid that are metabolized into dihydroxyepoxyeicosatrienoic acids (DHET) by soluble epoxide hydrolase (sEH). The current investigations were performed to examine the cardioprotective effects of UA-8 (13-(3-propylureido)tridec-8-enoic acid), a synthetic compound that possesses both EET-mimetic and sEH inhibitory properties, against ischaemia-reperfusion injury. Experimental Approach Hearts from C57BL/6 mice were perfused in Langendorff mode and subjected to ischaemia reperfusion. Mechanistic studies involved co-perfusing hearts with either 14,15-EEZE (a putative EET receptor antagonist), wortmannin or PI-103 (class-I PI3K inhibitor). H9c2 cells were utilized to investigate the protective effects against mitochondrial injury following anoxia reoxygenation. Key Results Perfusion of UA-8 significantly improved postischaemic left ventricular developed pressure (LVDP) and reduced infarction following ischaemia reperfusion compared with control and 11,12-EET. UA-7 (13-(2-(butylamino)-2-oxoacetamido) tridec-8(Z)-enoic acid), a compound lacking sEH inhibitory properties, also improved postischaemic LVDP, while co-perfusion with 14,15-EEZE, wortmannin or PI-103 attenuated the improved recovery. UA-8 prevented anoxia-reoxygenation induced loss of mitochondrial membrane potential and cell death in H9c2 cells, which was blocked by co-treatment of PI-103. Conclusions and Implications UA-8 provides significant cardioprotection against ischaemia reperfusion injury. The effects are attributed to EETs mimetic properties, which limits mitochondrial dysfunction via class-I PI3K signalling.

AB - Background and Purpose Epoxyeicosatrienoic acids (EETs) are cytochrome P450 epoxygenase metabolites of arachidonic acid that are metabolized into dihydroxyepoxyeicosatrienoic acids (DHET) by soluble epoxide hydrolase (sEH). The current investigations were performed to examine the cardioprotective effects of UA-8 (13-(3-propylureido)tridec-8-enoic acid), a synthetic compound that possesses both EET-mimetic and sEH inhibitory properties, against ischaemia-reperfusion injury. Experimental Approach Hearts from C57BL/6 mice were perfused in Langendorff mode and subjected to ischaemia reperfusion. Mechanistic studies involved co-perfusing hearts with either 14,15-EEZE (a putative EET receptor antagonist), wortmannin or PI-103 (class-I PI3K inhibitor). H9c2 cells were utilized to investigate the protective effects against mitochondrial injury following anoxia reoxygenation. Key Results Perfusion of UA-8 significantly improved postischaemic left ventricular developed pressure (LVDP) and reduced infarction following ischaemia reperfusion compared with control and 11,12-EET. UA-7 (13-(2-(butylamino)-2-oxoacetamido) tridec-8(Z)-enoic acid), a compound lacking sEH inhibitory properties, also improved postischaemic LVDP, while co-perfusion with 14,15-EEZE, wortmannin or PI-103 attenuated the improved recovery. UA-8 prevented anoxia-reoxygenation induced loss of mitochondrial membrane potential and cell death in H9c2 cells, which was blocked by co-treatment of PI-103. Conclusions and Implications UA-8 provides significant cardioprotection against ischaemia reperfusion injury. The effects are attributed to EETs mimetic properties, which limits mitochondrial dysfunction via class-I PI3K signalling.

KW - cardioprotection

KW - EET surrogates

KW - ischaemia-reperfusion

KW - mitochondria and sEHi

UR - http://www.scopus.com/inward/record.url?scp=79251476881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251476881&partnerID=8YFLogxK

U2 - 10.1111/j.1476-5381.2010.01093.x

DO - 10.1111/j.1476-5381.2010.01093.x

M3 - Article

VL - 162

SP - 897

EP - 907

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -